On March 23, Lepu SARS-CoV-2 Antigen Test Kit was granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) for self-testing in Germany. This allows the users to apply tests at home with the aid of sample nasal swabs.
The rapid antigen test is easy to operate compared with PCR testing. It collects the sample from nasopharynx. Users can test by themselves at home where they might feel most comfortable. By following simple instructions, they can get the results ready in 15 minutes.
On March 17, the European Center for Disease Prevention and Control published an announcement regarding the public’s usage of self-tests to detect SARS-CoV-2. “From a public health perspective, self-tests can offer advantages when used to complement professionally administered RADTs or RT-PCR tests. They can improve the accessibility to testing. They allow individuals to obtain the result very quickly, which could support the early detection of infectious cases and reduce further community transmission.”
So far, Lepu's anti-covid-19 products have reached over 147 countries worldwide. This time, Lepu home-use antigen test kits facilitated disease control process in Germany and would continue to support that within Europe soon. More details of Lepu SARS-CoV-2 Antigen Rapid Test Kit, please visit: https://en.lepumedical.com/products/sars-cov-2-antigen-rapid-test-kit-colloidal-gold-immunochromatography/